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VNTRAbstract Background and purpose: Monoamine oxidase A (MAOA, Xp11.3; OMIM: 309850) can
modulate the level of neurotransmitters in the central nervous system. A 30 bp variable number of
tandem repeat (VNTR) genetic polymorphism on the promoter region of theMAOA can modulate
the transcriptional activity of the gene. Association between this polymorphism and dependency to
methamphetamine was investigated.
Subjects and methods: A total of 65 methamphetamine abusers (52 males and 13 females) and
635 healthy controls (525 males and 110 females) were included in the present case–control study.
Genotypic analysis for the MAOA VNTR polymorphism was determined by conventional PCR.
Based on transcriptional activity of the VNTR alleles, the alleles were categorized into two classes:
L allele (2R and 3R alleles) and H allele (3.5R, 4R and 5R alleles), which have low and high tran-
scriptional activities, respectively.
Results: Our data show that the H allele significantly increases the risk of methamphetamine
dependence in males (OR = 2.03, 95% CI: 1.04–3.67, P= 0.037). The H allele seems positively
associated with the risk of dependency to methamphetamine among females, but the observed
OR did not reach the significance level, probability due to small sample size of the patients.
Conclusion: The present study supports the role of the VNTR polymorphism on the promoter
region of the MAOA on methamphetamine dependence.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Monoamine oxidase A (MAOA, Xp11.3; OMIM: 309850) oxi-
dizes neurotransmitters. It can modulate the level of neuro-
transmitters in the central nervous system and plays an
112 K. Saify, M. Saadatimportant role in many behaviors such as violence, criminal,
and drug dependence [1–6]. Previously several genetic poly-
morphisms were reported in the gene encoding MAOA (). A
30 bp sequence within the core promoter region of the MAOA
was found to occur as a polymorphic element, either singular
or as tandemly repeated 2, 3, 3.5, 4 or 5 times [7–9]. This poly-
morphic site is located 1.2 kb upstream of the MAOA coding
sequence. Studies have shown that the 3.5R, 4R and 5R alleles
of this variable number of tandem repeats (VNTRs) were more
active than the other alleles (2R and 3R) [8].
There were several studies investigating the association
between this genetic variation and susceptibility to drug depen-
dence, including alcohol, heroin and methamphetamine [2–
4,6,10–13]. However, the results were not consistent. Based
on our knowledge there was only one study investigating the
association between the MAOA VNTR polymorphism and
susceptibility to methamphetamine dependence in the Japanese
population [3]. There was no study from Caucasian popula-
tions. Therefore, the present case–control study was carried
out.2. Subjects and methods
2.1. Participants
A detailed description of the study subjects has been reported
in our previous reports [14,15]. A total of 65 metham-
phetamine abusers (52 males and 13 females) and 635 healthy
controls (525 males and 110 females) were included in the pre-
sent case–control study. The mean age (SD) of the patients and
the controls were 35.0 (8.5) and 33.6 (9.0) years, respectively.
The patients were assessed using the Structured Clinical Inter-
view based on Diagnostic and Statistical Manual of Mental
Disorders, fourth edition (DSM-IV) criteria for metham-
phetamine dependence. Moreover, urine drug screens were
obtained. All patients were interviewed by a senior
psychiatrist.
Considering that in the genetic association studies we are
going to compare the frequency of the genotypes (or the alle-
les) between cases and controls, it is necessary to select both
groups from a gene pool (because allelic frequency may show
a difference between gene pools). This point strongly recom-
mended by STrengthening the REporting of Genetic Associ-
ation studies (STREGA) [16]. However, it should be noted
that the Iranian gene pool is one of the most heterogeneous
gene pools [17–19]. Therefore, we select our patients and con-
trols from Persians (Caucasians/Muslims) living in Fars pro-
vince. Data on ethnicity were collected using simple questions
like the parental and grandparental ethnicity (and also the
religion) of each participant. Participants whose mothers
and fathers (and also their grandparents) did not belong to
Persians or to non-Muslim religious communities were
excluded.
This study was approved by the Shiraz University ethics
committee and informed consent was obtained from each sub-
ject before the study. The work has been carried out in accor-
dance with The Code of Ethics of the World medical
association (Declaration of Helsinki) for experiments in
humans.
Using the QUANTO (http://biostats.usc.edu/software)
software, to detect a real difference in genotypic frequencywith a power of 0.80, a= 0.05, OR= 1.75, 40% frequency
of the minor allele, and if the ratio of case/control be equal
to 1/10; a minimum sample of 136 would be necessary.
2.2. Genotyping analysis
Peripheral blood samples were collected from the participants.
Genomic DNA was isolated from EDTA treated blood sam-
ples. Genotypic analysis for theMAOA VNTR polymorphism
was determined by the PCR assay, using specific primers as
described previously [6]. In brief, conventional PCR amplifica-
tion was performed using the following with 50-ACA GCC
TGA CCG TGG AGA AG-30 (forward) and 50-GAA CGG
ACG CTC CAT TCG GA-30 (reverse) primers [6]. PCR con-
ditions consisted of an initial denaturation step of 94 C for
5 min, followed by 30 cycles of 94 C for 30 s, 68 C for 45 s
and 72 C for 45 s, a final extension of 72 C for 5 min. PCR
products were subjected to 2.5% agarose gel electrophoresis
and then visualized with a gel imaging system to determine
genotypes.
Alleles containing 2, 3, 4 or 5 repeats gave products with the
following lengths of 294, 324, 354, and 384 bp, respectively.
Based on transcriptional activity of the VNTR alleles, the alle-
les were categorized into two classes. The 2R and 3R alleles
(L allele) have lower transcriptional activity corresponding
with lower expression level, while the 3.5R, 4R and 5R (H
allele) have higher transcriptional activity corresponding with
higher expression [8].
2.3. Statistical analysis
Chi-square test was performed for the polymorphism to deter-
mine if the control group demonstrated the Hardy–Weinberg
equilibrium. The association between the genotypes and risk
of dependence to methamphetamine was assessed by calculat-
ing odds ratios (ORs) and 95% confidence intervals (CIs).
Statistical analysis was performed using the Statistical Package
for Social Sciences (SPSS Inc., Chicago, IL, USA) (version
11.5). A probability of P< 0.05 was considered statistically
significant. All P values were two-tailed.
3. Results
The gene encoding MAOA is located on the human chromo-
some X, therefore we should report the genotypes of the
MAOA VNTR polymorphism in each gender. Table 1 shows
the genotypic frequency of the polymorphism in cases and
healthy controls. Table 2 shows the distribution of the geno-
types according to the L and H alleles.
There was no significant difference between gender groups
for the frequency of the H and L alleles (v2 = 3.37, df= 1,
P= 0.066). The observed genotypic frequency in the females
of the control group was in agreement with Hardy–Weinberg
equilibrium (v2 = 1.58, df= 1, P= 0.208).
The present data indicate that the H allele significantly
increases the risk of methamphetamine dependence in males
(OR = 2.03, 95% CI = 1.04–3.97, P= 0.037) (Table 2).
Our statistical analysis revealed that the combination geno-
types of LH +HH (versus the LL genotype; dominant pene-
trate condition) were not associated with the risk of
methamphetamine dependence among females (OR = 3.71,
Table 1 Genotypic distribution of the MAOA VNTR
polymorphism in healthy control and methamphetamine
dependent subjects, cases stratified by gender.
Genotypes/Gender Controls Cases
Females
2R/2R 1 –
2R/4R 1 –
3R/3R 25 1
3R/4R 44 7
3R/5R 3 –
4R/4R 34 5
4R/5R 2 –
Total 110 13
Males
2R 6 –
3R 193 12
4R 306 38
5R 20 2
Total 525 52
Table 2 Association between genetic polymorphism of 30 bp
VNTR polymorphism ofMAOA and risk of methamphetamine
dependence.
Genotypes/Alleles Controls Cases OR 95% CI P-value
Males
L 199 12 1.0 – –
H 326 40 2.03 1.04–3.97 0.037
Females
LL 26 1 1.0 – –
LH 48 7 3.79 0.44–32.5 0.224
HH 36 5 3.61 0.39–32.7 0.254
LH+HH 84 12 3.71 0.46–29.9 0.218
L 100 9 1.0 – –
H 120 17 1.57 0.67–3.68 0.296
Association between VNTR polymorphism and methamphetamine dependence 11395% CI: 0.46–29.9, P= 0.218). The H allele seems positively
associated with the risk of dependency to methamphetamine
among females (OR = 1.57, 95% CI: 0.67–3.68, P= 0.296),
but the observed OR did not reach the significance level, prob-
ability due to small samples size of the patients (Table 2).
4. Discussion
It should be noted that only one study has reported the asso-
ciation between MAOA VNTR polymorphism and depen-
dency to methamphetamine in a Japanese population, which
reported no significant association [3]. However, our present
study indicating that the H allele of the study polymorphism
was associated with the risk of methamphetamine abused at
least in males (Table 2).
We know that association between a genetic polymorphism
and a multifactorial trait was not similar between different
ethnic groups [20–23]. It is possible that the discrepancy
between findings of the present study with the study of
Nakamura et al., [3], at least in part, may be interpreted by
the ethnicity of the participants (Asians and Caucasians).However, it is very premature to conclude in which ethnic
groups this polymorphism is associated with risk of metham-
phetamine dependence.
It should be noted that very recently we reported no signif-
icant association between the study polymorphism and the risk
of heroine dependence in our population [13]. It might be con-
cluded that the mechanisms involved in dependency to heroin
and methamphetamine is not similar, at least in our
population.
Finally, the small sample size (especially in the metham-
phetamine dependent cases) is the major limitation of the pre-
sent study. Therefore, the contribution of the VNTR genetic
polymorphism on the promoter region of theMAOA in depen-
dency to methamphetamine should be further researched on
other populations.Disclosure statement
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